Tubacin, a selective HDAC6 inhibitor, was found to alleviate ischemic brain injury in T2D mice with focal cerebral ischemia by endorsing eNOS expression in an HDAC6-dependent mechanism [330]. Here, HDAC6 is linked to brain ischemia.